Vincent Anzalone | Vice President of Investor Relations |
Christopher Anzalone | President and Chief Executive Officer |
Javier San Martin | Chief Medical Officer |
Ken Myszkowski | Chief Financial Officer |
James Hassard | Chief Commercial Officer |
James Hamilton | Senior Vice President and Head of Discovery and Translational Medicine |
Shawn Egan | Citigroup |
Maury Raycroft | Jefferies |
Alethia Young | Cantor Fitzgerald |
Salveen Richter | Golden Sachs |
Ted Tenthoff | Piper Sandler |
Mani Foroohar | SVB Leerink |
Luca Issi | RBC Capital |
Madhu Kumar | Baird |
Mayank Mamtani | B. Riley |
Patrick Trucchio | H.C. Wainwright |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.